← Browse by Condition
Medical Condition

gastrointestinal diseases

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for gastrointestinal diseases sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — gastrointestinal diseases Clinical Trials

How many clinical trials are currently recruiting for gastrointestinal diseases?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for gastrointestinal diseases, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for gastrointestinal diseases?
gastrointestinal diseases research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a gastrointestinal diseases clinical trial?
Eligibility criteria for gastrointestinal diseases trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 4
1
Top Sponsors
The University of Queensland 1 trial
EP Plus Group Sdn Bhd 1 trial
Jiangxi Provincial Cancer Hospital 1 trial
Chinese University of Hong Kong 1 trial

Recruiting Clinical Trials

NCT05274854
Recruiting
A Practice Change for Patients With Severe Chronic, Clinically Unexplained Gastrointestinal Symptoms
Enrollment
200 pts
Location
Australia
Sponsor
The University of Queensland
View Trial →
NCT06271538 Phase 4
Recruiting
Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
Enrollment
60 pts
Location
Malaysia
Sponsor
EP Plus Group Sdn Bhd
View Trial →
NCT05252078 Phase 2
Recruiting
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
Enrollment
30 pts
Location
China
Sponsor
Jiangxi Provincial Cancer Hosp...
View Trial →
NCT05467527
Recruiting
PACT Programme for Parents of Children With SHCN
Enrollment
196 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
View Trial →

Related Conditions

irritable bowel syndrome (2) colonic diseases functional (1) intestinal disease (1) digestive system disease (1) pathologic processes (1) colonic disease (1) disease (1) esophageal squamous cell carcinoma (1) esophageal neoplasms (1) esophageal diseases (1) gastrointestinal neoplasms (1) digestive system neoplasms (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology